Evidence map›Paper›PMID 28868130›Full record

ReviewF1000Research2017

Bacterial lipids: powerful modifiers of the innate immune response.

Courtney E Chandler, Robert K Ernst

Open access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Metabolites · 2025
    Article
  7. Article
  8. Review
  9. BECC-engineered live-attenuatedResearch square · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Role ofFrontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Courtney E ChandlerDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, 650 W. Baltimore Street, 8th Floor South, Baltimore, MD, 21201, USA.
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, 650 W. Baltimore Street, 8th Floor South, Baltimore, MD, 21201, USA.ORCID https://orcid.org/0000-0001-5016-8694
University of Maryland, Baltimore · US

Funding

MS diagnostic bacterial identification libraryR01GM111066 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, GOODLETT, DAVID ROBINSON · 2014 to 2017
$1.2M
Immunotherapeutic Potential of Modified Lipooligosaccharides and Lipid A'sR21AI101685 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K · 2013 to 2014
$411k
NIAID NIH HHS R21 AI101685NIGMS NIH HHS R01 GM111066
6 · The paper itself

Abstract

The innate immune system serves as a first line of defense against microbial pathogens. The host innate immune response can be triggered by recognition of conserved non-self-microbial signature molecules by specific host receptor proteins called Toll-like receptors. For bacteria, many of these molecular triggers reside on or are embedded in the bacterial membrane, the interface exposed to the host environment. Lipids are the most abundant component of membranes, and bacteria possess a unique set of lipids that can initiate or modify the host innate immune response. Bacterial lipoproteins, peptidoglycan, and outer membrane molecules lipoteichoic acid and lipopolysaccharide are key modulators of the host immune system. This review article will highlight some of the research emerging at the crossroads of bacterial membranes and innate immunity.

Indexed as

innate immunitylipoproteinsLPSLTATLR2TLR4

Identifiers

PMID28868130
PMCPMC5553087
OpenAlexW2743403375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.